Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent features.
Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent features. Sci Adv. 2024 11 15; 10(46):eadq0856.
PMID: 39546597
Deep learning generates synthetic cancer histology for explainability and education.
Deep learning generates synthetic cancer histology for explainability and education. NPJ Precis Oncol. 2023 May 29; 7(1):49.
PMID: 37248379
Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer.
Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer. NPJ Breast Cancer. 2022 Jul 22; 8(1):88.
PMID: 35869114
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. Lancet Oncol. 2022 01; 23(1):149-160.
PMID: 34902335
Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer.
Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer. Mod Pathol. 2020 09; 33(9):1746-1752.
PMID: 32300181
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity. Cancer Res. 2016 12 15; 76(24):7118-7129.
PMID: 27913435